Jose Ramon Murillo, Jr., Pharm.D., BCOP
Reportable Conflicts of Interests: None
Disclosure of Financial Conflicts of Interest: None
Education:
Doctor of Pharmacy
The University of Texas at Austin
Austin, TX
The University of Texas Health Sciences Center
San Antonio, TX
Bachelors of Science in Biology
The University of Texas at San Antonio
San Antonio, TX
Post Graduate or Residency Training:
ASHP Accredited Hematology/Oncology Specialty Residency 07/2003-07/2004
South Texas Veterans Health Care System
San Antonio, TX
ASHP Accredited Pharmacy Practice Residency 07/2002-07/2003
Dallas VA Medical Center
Dallas, Tx
Fellowship and Board Certifications:
Board Certified Oncology Pharmacist
Advanced Cardiac Life Support
Pharmacist Preceptor Certificate
Basic Cardiac Life Support
Current Position or Practice Site:
Adjunct Clinical Assistant Professor
University of Houston
College of Pharmacy
Clinical Instructor
The University of Texas at Austin
College of Pharmacy
Clinical Specialist II-Hematology/Oncology
The Methodist Hospital
Houston, Texas
Past Positions and/or Appointments:
Clinical Instructor 07/2003-07/2004
The University of Texas at Austin-College of Pharmacy
University of Texas Health Science Center
San Antonio, TX
Assistant Instructor 07/2002-07/2003
Texas Tech University Health Sciences Center
School of Pharmacy
Amarillo, TX
Research Intern/Assistant 05/1996-08/1996
University of North Texas Health Science Center
Fort Worth, TX
Professional Memberships:
American Society of Clinical Oncology
Hematology-Oncology Pharmacy Association
American College of Clinical Pharmacy
American Society of Health-System Pharmacists
Texas Society of Health-System Pharmacists
Gulf Coast Society of Health-System Pharmacists
American Pharmaceutical Association
Publications:
Central Nervous System Complications of Chemotherapeutic Agents. Murillo JR, Oholendt MS, Cox JE. (Manuscript under review)
Abbreviated, Weight-based Bevacizumab Infusons: Assessment of Patient Safety and Satisfacton. Hart JW, Murillo JR, Oholendt MS, Preti HA. (Manuscript in progress)
OncologySTAT by Elsevier. Contributor/Reviewer for breast cancer regimens and supportive care. Elsevier Incorporated © 2008; www.oncologystat.com.
An Overview of Chemotherapy-Induced Peripheral Neuropathy. Murillo JR, Cox JE, Oholendt MS. Journal of Pharmacy Practice 2008;21(2):138-145.
Assessment of Safety with Abbreviated, Weight-based Bevacizumab Infusions in a Variey of Solid Tumors. Hart JW, Murillo JR, Oholendt MS, Preti HA. 2007 ASCO Annual Meeting Proceedings. JCO 2007;25(18S)Part I:721s. (Abstract)
The Elsevier Guide to Oncology Drugs & Regimens. Contributor/Reviewer for breast cancer regimens and supportive care. Elsevier Oncology © 2006; Huntington, New York. www.oncologydrugguide.com.
Chemotherapy Given Near the End of Life by Community Oncologsts for Advanced Non-Small Cell Lung Cancer. Murillo JR and Koeller J. The Oncologist 2006;11:1095-1099.
Tegaserod-Induced Myocardial Infarction: Case Report and Hypothesis – An Alternative Veiwpoint. (Authors’ Reply) – Busti AJ, Murillo JR, Cryer B. Pharmacotherapy 2004;24(11):1649-1650.
Tegaserod-Induced Myocardial Infarction: Case Report and Hypothesis. Busti AJ, Murillo JR, Cryer B. Pharmacotherapy 2004;24(4):526-531.
Adenosine Receptor Blockade Enhances Glycolysis in Hypoperfused Guinea-Pig Myocardium. Gao ZP, Downey HF, Sun J, He MX, and Mallet RT. Cardiovascular Research 1997;33:31-44. (Acknowledgement)
(Last Updated: 3/24/2009)
